Dougherty & Co Comments on IntriCon Co.’s Q1 2018 Earnings (IIN)

IntriCon Co. (NASDAQ:IIN) – Equities researchers at Dougherty & Co issued their Q1 2018 earnings per share estimates for IntriCon in a research note issued on Tuesday. Dougherty & Co analyst R. Ryan forecasts that the technology company will post earnings of $0.06 per share for the quarter. Dougherty & Co also issued estimates for IntriCon’s FY2018 earnings at $0.62 EPS.

A number of other equities research analysts have also issued reports on the company. TheStreet raised IntriCon from a “c” rating to a “b-” rating in a research report on Wednesday, November 8th. Zacks Investment Research lowered IntriCon from a “buy” rating to a “hold” rating in a research report on Wednesday. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. IntriCon presently has a consensus rating of “Hold” and a consensus price target of $17.00.

Shares of IntriCon (NASDAQ IIN) opened at $19.75 on Wednesday. The company has a quick ratio of 0.54, a current ratio of 1.45 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of $124.67, a price-to-earnings ratio of 64.82, a PEG ratio of 1.51 and a beta of 0.12. IntriCon has a twelve month low of $6.05 and a twelve month high of $24.00.

IntriCon (NASDAQ:IIN) last announced its quarterly earnings data on Monday, February 12th. The technology company reported $0.07 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.06 by $0.01. The business had revenue of $22.23 million during the quarter. IntriCon had a return on equity of 10.82% and a net margin of 2.04%.

In other news, VP Michael Geraci sold 2,737 shares of the business’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $17.60, for a total transaction of $48,171.20. Following the sale, the vice president now directly owns 22,011 shares of the company’s stock, valued at $387,393.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 21.40% of the stock is owned by insiders.

A number of large investors have recently bought and sold shares of IIN. EAM Investors LLC raised its position in IntriCon by 185.6% during the fourth quarter. EAM Investors LLC now owns 138,873 shares of the technology company’s stock valued at $2,750,000 after buying an additional 90,253 shares during the period. Algert Global LLC raised its position in IntriCon by 165.7% during the fourth quarter. Algert Global LLC now owns 87,059 shares of the technology company’s stock valued at $1,724,000 after buying an additional 54,299 shares during the period. Renaissance Technologies LLC raised its position in IntriCon by 21.5% during the fourth quarter. Renaissance Technologies LLC now owns 288,600 shares of the technology company’s stock valued at $5,714,000 after buying an additional 51,000 shares during the period. Essex Investment Management Co. LLC acquired a new position in IntriCon during the third quarter valued at $267,000. Finally, Prescott Group Capital Management L.L.C. acquired a new position in IntriCon in the 4th quarter worth about $366,000. 31.45% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This report was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at

About IntriCon

IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with's FREE daily email newsletter.

Leave a Reply